/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Lysosomal

Lysosomal

Cambridge, United States

Lysosomal Therapeutics, Inc. discovers and develops new therapies for patients with severe neurological diseases affecting movement, cognition and general health.

Healthcare & Biotech

Lysosomal, based in Cambridge, United States, has 2 investors on file, among them Atlas Venture and Hatteras Venture Partners. Its site was last checked 7 Nov 2026: site answers.

lysosomaltx.org

Investors

2 investors on file
InvestorEvidenceType
Atlas VenturePortfolio pageVenture capital
Hatteras Venture PartnersPortfolio pageVenture capital

More from Atlas Venture

52 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (93%), Industrial & Manufacturing (2%), Robotics & Hardware (2%).

Accent TherapeuticsAccent Therapeutics develops small molecule therapeutics for patients …Alnylam PharmaceuticalsAlnylam Pharmaceuticals develops RNAi therapeutics.Bicycle TherapeuticsBicycle Therapeutics is developing precision-guided therapeutics to ta…Cogent BiosciencesCogent Biosciences conducts clinical trials and develops treatments fo…ComancheComanche Biopharma is a biopharmaceutical company developing an invest…

See Atlas Venture's full profile · Who invests alongside it

More from Hatteras Venture Partners

61 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (92%), Education (3%), AI & Machine Learning (3%).

410 MedicalThe company develops and sells a hand-operated rapid infuser for deliv…AN2 TherapeuticsAN2 Therapeutics develops boron-based medicines for various diseases, …Aer TherapeuticsAer Therapeutics develops a therapy to liquify mucus plugs in the lung…AvivomedAvivomed is developing neuromodulation therapies for patients sufferin…Axonis TherapeuticsAxonis Therapeutics develops medicines targeting neurological disorder…

See Hatteras Venture Partners' full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Lysosomal and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Atlas Venture adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/lysosomaltx.org/investors

# also
GET /v1/companies/lysosomaltx.org
GET /v1/companies/lysosomaltx.org/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing